Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study.
Kang YK, Morita S, Satoh T, Ryu MH, Chao Y, Kato K, Chung HC, Chen JS, Muro K, Kang WK, Yeh KH, Yoshikawa T, Oh SC, Bai LY, Tamura T, Lee KW, Hamamoto Y, Kim JG, Chin K, Oh DY, Minashi K, Cho JY, Tsuda M, Sameshima H, Chen LT, Boku N.
Kang YK, et al. Among authors: kang wk.
Gastric Cancer. 2022 Jan;25(1):207-217. doi: 10.1007/s10120-021-01230-4. Epub 2021 Sep 4.
Gastric Cancer. 2022.
PMID: 34480657
Free PMC article.
Clinical Trial.